Yaqrit Ltd.

ACTIVE

United Kingdomwww.yaqrit.comSubsidiary11–50 employeesEstablished: 2015-01-01

Part of yaqrit discovery ltd.

Clinical Trials

1 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2015

Overview

Trial Phase Distribution

Phase

Trials

Not Applicable

71.4%

Phase 2

28.6%

Trial Status Distribution

Active, not recruiting

14.3%

Completed

28.6%

Recruiting

28.6%

Terminated

14.3%

Withdrawn

14.3%

Clinical Trials

Trials sponsored by this organization (7)

A Novel Extracorporeal Liver Support Therapy In ALCF and to Evaluate the Efficacy of DIALIVE 2.0, a Liver Dialysis Device.

Not Applicable

Recruiting

interventional

Oct 202672 participants

A-TANGO Phase 2 Study

Phase 2

Recruiting

interventional

Jun 202678 participants

Phase II, double-blind, randomized, placebo-controlled, multicentre study to evaluate the safety, efficacy, and pharmacokinetics of TAK-242 and Granulocyte Colony-Stimulating Factor (G-CSF) (G-TAK) in subjects with severe alcoholic hepatitis (sAH) and acute-on-chronic liver failure (ACLF)

Phase 2

Active, not recruiting

interventional

Dec 202278 participants

Safety and Tolerability of Yaq-001 in Patients With Non-Alcoholic Steatohepatitis

Safety and Tolerability of Yaq-001 in Patients With Cirrhosis

Not Applicable

Terminated

interventional

Feb 201931 participants

Safety and Performance Trial of DIALIVE Liver Dialysis Device in Acute On Chronic Liver Failure Patients

Not Applicable

Completed

interventional

Jul 201730 participants

Safety and tolerability of Yaq-001 in patients with cirrhosis

Not Applicable

Completed

interventional

May 201756 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations